AKOYA BIOSCIENCES INC (AKYA) Stock Price, Quote, News and Overview
NASDAQ:AKYA - Nasdaq - US00974H1041 - Common Stock - Currency: USD
AKYA Quote, Performance and Key Statistics
AKOYA BIOSCIENCES INC
NASDAQ:AKYA (2/5/2025, 9:49:08 AM)
2.7
+0.08 (+3.05%)
The current stock price of AKYA is 2.7 USD. In the past month the price increased by 7.82%. In the past year, price decreased by -56.77%.
AKYA Latest News, Press Releases and Analysis
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
Rapid menu expansion with new high-plex human and mouse neurobiology panels joining the recently launched Human IO60 and Mouse FFPE IO Panels The new...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SSTK, AKYA, POAI on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders
AKYA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 26.65 | 222.81B | ||
| DHR | DANAHER CORP | 28.45 | 153.92B | ||
| A | AGILENT TECHNOLOGIES INC | 27.83 | 41.99B | ||
| IQV | IQVIA HOLDINGS INC | 18.78 | 37.02B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.43 | 28.52B | ||
| WAT | WATERS CORP | 36.2 | 24.48B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 48.86 | 23.92B | ||
| ILMN | ILLUMINA INC | 72.87 | 19.99B | ||
| ICLR | ICON PLC | 13.87 | 16.06B | ||
| AVTR | AVANTOR INC | 22.71 | 15.15B | ||
| RVTY | REVVITY INC | 25.15 | 15.00B | ||
| TECH | BIO-TECHNE CORP | 43.65 | 12.41B |
Related stock screener links
About AKYA
Company Profile
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company is headquartered in Marlborough, Massachusetts and currently employs 330 full-time employees. The company went IPO on 2021-04-16. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. The company offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
Company Info
AKOYA BIOSCIENCES INC
100 Campus Drive, 6th Floor
Marlborough MASSACHUSETTS US
CEO: Brian McKelligon
Employees: 330
Company Website: https://www.akoyabio.com/
Investor Relations: http://investors.akoyabio.com
Phone: 18558968401
AKYA FAQ
What is the stock price of AKYA?
The current stock price of AKYA is 2.7 USD.
What is the symbol for AKOYA BIOSCIENCES INC stock?
The exchange symbol of AKOYA BIOSCIENCES INC is AKYA and it is listed on the Nasdaq exchange.
On which exchange is AKYA stock listed?
AKYA stock is listed on the Nasdaq exchange.
Is AKYA a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for AKYA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of AKYA.
Does AKYA stock pay dividends?
AKYA does not pay a dividend.
What is the Price/Earnings (PE) ratio of AKYA?
AKYA does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.18).
What is the Short Interest ratio of AKYA stock?
The outstanding short interest for AKYA is 8.46% of its float.
AKYA Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to AKYA. When comparing the yearly performance of all stocks, AKYA is a bad performer in the overall market: 92.8% of all stocks are doing better.
AKYA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AKYA. AKYA may be in some trouble as it scores bad on both profitability and health.
AKYA Financial Highlights
Over the last trailing twelve months AKYA reported a non-GAAP Earnings per Share(EPS) of -1.18. The EPS increased by 30.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -44.6% | ||
| ROE | -425.2% | ||
| Debt/Equity | 5.62 |
AKYA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to AKYA. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of 21.9% and a revenue growth -14.84% for AKYA